| Item |
Information |
|
Drug Groups
|
illicit; approved |
|
Description
|
Talbutal, also called 5-allyl-5-sec-butylbarbituric acid, is a barbiturate with a short to intermediate duration of action. Talbutal is a schedule III drug in the U.S. |
| Indication |
For use as a sedative and hypnotic. |
| Pharmacology |
Talbutal is a short to intermediate-acting barbiturate. Barbiturates act as nonselective depressants of the central nervous system (CNS), capable of producing all levels of CNS mood alteration from excitation to mild sedation, hypnosis, and deep coma. In sufficiently high therapeutic doses, barbiturates induce anesthesia. |
| Toxicity |
Symptoms of acute barbiturate poisoning include drowsiness, confusion, coma, respiratory depression, hypotension, and shock. |
| Affected Organisms |
| • |
Humans and other mammals |
|
| External Links |
|
|